Timothy O'Shea, PharmD, MS, discussed the most surprising findings from a home infusion pilot program and explained how he thinks home infusion will continue to evolve.
Chelsee Jensen, PharmD, BCPS, of Mayo Clinic, commented on the recent FDA biosimilar approvals and what they mean for the industry's future, as well as how to ensure biosimilars are accessible to all patients.
Jeff McIntyre, MA, of the Global Liver Institute, discussed how the delayed diagnosis of non-alcoholic steatohepatitis (NASH) affects patients and how health care and managed care professionals can help expedite diagnosis and treatment.
Ben Urick, PharmD, PhD, of Prime Therapeutics compared the value of medically integrated specialty pharmacies to that of mail-order pharmacies in a video interview on site at AMCP Nexus in Orlando, Florida.
Jennifer Mathieu, MA, senior vice president of professional and government affairs of the Academy of Managed Care Pharmacy (AMCP), described what is in store for attendees during next week's AMCP Nexus meeting.